HDI Publications by date
Search will default to “all years” unless you filter by a specific year below.
Variability in Kidney Cancer Treatment and Survival in England
K Fife, C Pearson, C S Knott, A Greaves, G D Stewart, Members of the Kidney Cancer Accord. Variability in Kidney ...
Factors associated with receipt of systemic anticancer treatment for locally advanced or metastatic urothelial carcinoma in England: a population-based study
Seyed Hamidreza Mahmoudpour, Craig Knott, Mairead Kearney, Leo Russo, Patrice Verpillat,Factors associated with ...
A comparison of frailty measures in population-based data for patients with colorectal cancer
Birch R, Taylor J, Rahman T, Audisio R, Pilleron S, Quirke P, Howell S, Downing A, Morris E. A comparison of ...
The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data resource
The comprehensive English National Lynch Syndrome Registry: development and description of a new genomics data ...
Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline analysis of the diagnostic pathway
Identification of people with Lynch syndrome from those presenting with colorectal cancer in England: baseline ...
Cohort study to assess geographical variation in cholangiocarcinoma treatment in England
Jose S, Zalin-Miller A, Knott C, Paley L, Tataru D, Morement H, Toledano MB, Khan SA. Cohort study to assess ...
Real-world evidence for patient outcomes and mutational burden in non-small cell lung (NSCLC) cancer patients in England using EGFR biomarker test data from routine clinical care
Hagenaars S, Ingleby FC, Lambova A, Gaultney J, Parimi M, Huynh J, Benson S, Muwaffak M, Jose S, Frayling L, ...
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from routine clinical practice in England
Real-world outcomes and biomarker testing in cancer patients: exploration of a novel genetic database from ...
First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma (aMCC) in England from 2013-2022: Results of a nationwide observational cohort study
First-line treatment (tx) patterns and overall survival (OS) of patients (pts) with advanced Merkel cell carcinoma ...
First-line treatment patterns and overall survival of patients with advanced Merkel cell carcinoma in England from 2013-2022: results of a nationwide observational cohort study
Knott CS, Mahmoudpour SH, Kearney M, Boutmy E, Verpillat P. First-line treatment patterns and overall survival of ...